PROTEINPOLYMERKONJUGATE

European patent · EP2205281 · In force

Register entry

Publication number
EP2205281
Application number
EP08797971
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 15, 2008
Published
Jul 14, 2010
Granted
Jun 29, 2022
Protection ends at the latest
Aug 14, 2028
Next annual fee due
Aug 31, 2027
IPC classes
A61K 47/50 (2017.01)
Priority
US 956273 P 16.08.2007
PCT application
PCT/US2008/073290 15.08.2008
PCT publication
WO2009/023826 19.02.2009
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Ropeginterferonum alfa-2b

C02205281/01 · Medicine · Granted · Protection from Aug 15, 2028 to Aug 14, 2033

Authorisation 67488 (Swissmedic, Jul 1, 2020)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. May 10, 2023

    Change

    Published in Swissreg on 10.05.2023

  6. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  7. Sep 6, 2022

    Change

    Published in Swissreg on 06.09.2022

  8. Aug 11, 2022

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 11.08.2022

1 earlier entry
  1. Jun 29, 2022

    Granted

    Published in Swissreg on 29.06.2022

Parties

Holder

PharmaEssentia Corp.

13F, No. 3. Park St., Nangang District,, Taipei 115, TW

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

LIN, Ko-Chung

Lexington, MA 02421, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.